Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,166 | 5,178 | 4,891 | 9,761 | 14,179 |
| Receivables | 300 | 50 | 200 | 350 | 500 |
| Other current assets | 0 | 187 | 317 | 337 | 41 |
| TOTAL | $1,826 | $5,415 | $5,408 | $10,448 | $14,720 |
| Non-Current Assets | |||||
| PPE Net | 72 | 75 | 78 | 82 | 85 |
| Intangibles | 2,242 | 2,409 | 2,577 | 2,745 | 2,913 |
| Other Non-Current Assets | 1,471 | 2,786 | 2,766 | 2,745 | 2,722 |
| TOTAL | $3,785 | $5,270 | $5,421 | $5,571 | $5,720 |
| Total Assets | $5,611 | $10,686 | $10,829 | $16,019 | $20,440 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,920 | 1,486 | 773 | 1,398 | 1,887 |
| Accrued Expenses | N/A | 192 | 192 | 124 | 1,983 |
| Other current liabilities | N/A | 3,342 | N/A | N/A | N/A |
| TOTAL | $2,142 | $5,376 | $1,689 | $1,835 | $4,123 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,142 | $5,376 | $1,689 | $1,835 | $4,123 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 364,773 | 243,895 | 212,829 | 212,829 | 205,031 |
| Common Shares | 365 | 244 | 213 | 213 | 205 |
| Retained earnings | -205,223 | -200,223 | -194,347 | -189,303 | -180,796 |
| TOTAL | $3,469 | $5,310 | $9,140 | $14,184 | $16,317 |
| Total Liabilities And Equity | $5,611 | $10,686 | $10,829 | $16,019 | $20,440 |